Sanofi-Aventis Farmacêutica Ltda in Consumer Health (Brazil)

September 2016 | 2 pages | ID: S70FA78A0FDEN
Euromonitor International Ltd

Abstracts

With the aim of returning to its leading position in consumer health in Brazil, Sanofi-Aventis Farmacêutica is set to continue investing in OTC products. This is set to be achieved mainly through the launch of new products and new packaging formats and by increasing its investment in its logistics and supply chain. In addition, the company is also expected to continue investing in dietary supplements over the forecast period.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
  Summary 1 Sanofi-Aventis Farmacêutica Ltda: Key Facts
Competitive Positioning
  Summary 2 Sanofi-Aventis Farmacêutica Ltda: Competitive Position 2016